Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients i...
Guardado en:
Autores principales: | Sebastian Figueroa-Bonaparte, Jaume Llauger, Sonia Segovia, Izaskun Belmonte, Irene Pedrosa, Elena Montiel, Paula Montesinos, Javier Sánchez-González, Alicia Alonso-Jiménez, Eduard Gallardo, Isabel Illa, Spanish Pompe group, Jordi Díaz-Manera |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92acffe4ea3d495381a7f63dd8c21825 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
por: Zhang B, et al.
Publicado: (2016) -
Late-onset Pompe disease (LOPD): May axial myopathy influence respiratory dysfunction?
por: Sabrina Ravaglia, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Alícia Dorneles Dornelles, et al.
Publicado: (2021) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: Javier de las Heras, et al.
Publicado: (2021) -
Molecular study of Pompe disease in Egyptian infants
por: Mona Essawi, et al.
Publicado: (2021)